Moderna stock surges as melanoma vaccine trial shows "landmark moment"
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
Watch CBS News
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
Moderna and Merck, its drug development partner, said the novel treatment prevented melanoma from returning or spreading in a study of high-risk melanoma patients.
The FDA has approved a new seasonal fly vaccine from Moderna called mFLUSIVA.
The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.
With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.
Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, announced Thursday that it will lay off about 10% of its workforce.
Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, announced Thursday that it will lay off about 10% of its workforce.
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.
The Cambridge-based company says the vaccine is at least as good as getting both vaccines separately, it will seek FDA approval next year.
Moderna announced that its combination COVID and flu vaccine showed positive results in a late-stage trial.
Moderna announced that its combination COVID and flu vaccine showed positive results in a late-stage trial.
WBZ-TV's Dr. Mallika Marshall reports.
Moderna said its updated COVID vaccine should protect against the highly-mutated new variant.
Vaccine maker Moderna said its updated Covid shot should protect against the highly-mutated new variant.
As temperatures rise, so do the number of ticks and the risk of Lyme disease. But the good news is an effective Lyme Disease vaccine is on the horizon.
Moderna's CEO defended a plan to more than quadruple the company's COVID-19 vaccine price,
WBZ TV's Kate Merrill reports.
WBZ-TV's Dr. Mallika Marshall reports.
WBZ TV's Paula Ebben reports.
WBZ TV's Dr. Mallika Marshall said there's no reason to be concerned about the bivalent booster shot.
Moderna on Friday filed patent infringement lawsuits against Pfizer and BioNTech "for infringing patents central to (its) mRNA technology platform," the company said in a news release Friday.
Moderna says its experimental COVID-19 vaccine that combines its original shot with protection against the omicron variant appears to work.
If we have a vaccine that could potentially protect millions of children, that can have a large public health impact, according to Dr. Mallika Marshall.
No Covid-19 vaccines have been authorized for children younger than 5 in the US -- about 18 million people.
